Biomerica vs Intelligent BIO Solutions
Biomerica and Intelligent BIO Solutions are similar in size: $4.5m and $4.2m of revenue in their latest fiscal years. Intelligent BIO Solutions grew faster (38.1% against -16.2%). Biomerica kept more of each dollar of sales as profit: a net margin of -84.8% against -294.9%. Biomerica carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | BiomericaBMRA, 2026 | Intelligent BIO SolutionsINBS, 2026 |
|---|---|---|
| Revenue | $4.5m | $4.2m |
| Revenue growth | -16.2% | 38.1% |
| Net income | −$3.8m | −$12.4m |
| Operating margin | -119.5% | -299.1% |
| Net margin | -84.8% | -294.9% |
| Return on equity | -112.1% | — |
| Free cash flow | −$3.4m | −$12.1m |
| Cash | $1.3m | $4.0m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 54 | — |
| Market value | $8.0m | $5.1m |
| Price vs our value range | — | — |
| Moat score | 10 (Weak) | — |
| Insider trades, 12 months | 5 buys, 0 sales | 0 buys, 0 sales |